Showing results (71-80 of 339) with videos related to

Sort By:
Pageof 34
Molecular Cancer|April 28, 2012
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatinCéline Jacquemont, Julian A Simon, Alan D D'Andrea, et al.
Molecular and Cellular Biology|September 1, 2006
Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistanceGary P H Ho, Steven Margossian, Toshiyasu Taniguchi, et al.
DNA Repair|November 29, 2005
Impaired DNA double strand break repair in cells from Nijmegen breakage syndrome patientsNiall G Howlett, Zorica Scuric, Alan D D'Andrea, et al.
Drug Discovery Today|April 30, 2024
AXL receptor as an emerging molecular target in colorectal cancerLucia De Rosa, Rossella Di Stasi, Virginia Fusco, et al.
Nature|February 22, 1990
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptorJ P Li, A D D'Andrea, H F Lodish, et al.
Molecular and Cellular Biology|February 1, 1993
Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell lineM O Showers, J C DeMartino, Y Saito, et al.
Blood|July 1, 1993
Anti-erythropoietin receptor (EPO-R) monoclonal antibodies inhibit erythropoietin binding and neutralize bioactivityA D D'Andrea, B J Rup, M J Fisher, et al.
Cancer Discovery|October 15, 2015
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian CancerPanagiotis A Konstantinopoulos, Raphael Ceccaldi, Geoffrey I Shapiro, et al.
Organic Letters|April 16, 2008
Semisynthesis of dimeric proteins by expressed protein ligationBarbara Ziaco, Soccorsa Pensato, Luca D D'Andrea, et al.
Blood|July 15, 1996
A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell linesY Shikama, D L Barber, A D D'Andrea, et al.
Pageof 34